Sand Hill Angels
VC Fund
Mountain View, United States
Sand Hill Angels is a group of Silicon Valley angel investors passionate about helping entrepreneurs get to the next level. What makes the group unique is the collective experience of its members building and scaling deep technology companies. The group has been around for more than two decades.Sand Hill Angels works openly and collaborativelywith venture capital funds, other angel organizations, and the Bay Area ecosystem that fosters the growth of technology startups. For additional information, visit www.sandhillangels.com or follow @SandHillAngels.com on Twitter.
- Total investments:
- 391
- Last investment:
- Lead investor:
- 3%
Last updated:
For AI agents: llms.txt
Industries Sand Hill Angels invests in
Stages Sand Hill Angels invests in
Countries Sand Hill Angels invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Seed
- $1M–$6.5M
- Series A
- $1.6M–$24M
- Series B
- $8.9M–$130M
Investment Focus
Industry
- Health Care 62 (16%)
- Software 59 (15%)
- Biotechnology 41 (10%)
- Medical 30 (8%)
- Artificial Intelligence 30 (8%)
Stage
- Seed 85 (22%)
- Series A 59 (15%)
- Series B 57 (15%)
- Convertible Note 54 (14%)
- Series C 30 (8%)
Country
- United States 258 (66%)
- Canada 4 (1%)
- India 3 (1%)
- El Salvador 3 (1%)
- Japan 1 (0%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Harper Cheng
Angel Investor
|
Angel Investor | Total investments: 0 | Find email | |
Matt Johnson
Member, Investor
|
Member, Investor | Total investments: 6 | Find email | |
Ralph Eschenbach
Vice President
|
Vice President | Total investments: 6 | Find email | |
Scott Thacker
Member
|
Member | Total investments: 0 | Find email | |
Todd Johnson
Investor & Member
|
Investor & Member | Total investments: 1 | Find email | |
| See all 40 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Crimson
|
Crimson is a AI productivity platform that allows litigation lawyers to answer case specific questions. | $2.5M / Seed / May 28, 2026 | |
Ratio
|
Ratio is a fintech platform that provides customers with flexible payment options, simplifying the procurement process. Ratio provides buy now, pay later services that integrate payments, predictive pricing, analytics, and finance, allowing B2B SaaS companies and other recurring revenue businesses to increase sales while gaining access to the valueof new contracts. Ratio allows businesses to leverage their recurring revenue streams to unlock new non-dilutive capital. | $15.8M / Venture - Series Unknown / Apr 14, 2026 | |
ImmuneBridge
|
ImmuneBridge is developing allogeneic immunotherapies for cancer. ImmuneBridge's key innovation fosters the development of immune stem cells obtained from cord blood and creates a fresh, adaptable, reliable, and plentiful cellular source for immunotherapies. They are currently looking for natural killer cell-based treatments for hematologicalcancers. They will then attack solid tumors using the special benefits of their cellular source. | $7.7M / Seed / Mar 23, 2026 | |
Lōvu Health
|
Lōvu Health is a digital maternal health platform that offers services to care for mother and baby from conception to postpartum. | $8M / Series A / Sep 10, 2025 | |
TrueMeter
|
EcoTrove is an AI Energy Agent that replaces unpredictable power bills with flat-price subscription to lower-cost, greener power. | Seed / Sep 10, 2025 | |
TrueMeter
|
TrueMeter is an AI Energy Manager that guarantees 7 - 15% lower power bills to brick & mortar businesses, with no investment required. | $4M / Seed / Sep 10, 2025 | |
Logomix
|
Logomix Inc is a mammalian cellular genome architect startup. Logomix proprietary platform, Geno-Writing™, technology integrates large-scale (Mb) human genome-writing technologies and providing genetically architected versatile human cells and/or downsized cells and microbes for drug development and cell & gene therapy area.Majority ofthe cell engineering companies are currently focused on optimization of gene clusters by automatic high throughput system however, Logomix’s Geno-Writing™ provides the required tools for dealing with mammalian or complex genomes. Logomix works with partners by providing new biology-based solutions to co-create business and social values on Geno-Writing™ platform Current Focus Area includes: 1. Human Health & Therapeutics 2. Biomaterials & Chemicals 3. Agriculture & EnvironmentLogomix has 11 ongoing collaborative research partnerships. Currently Logomix is specifically looking for industry partners to address unmet needs in neurodegenerative disease areas. | $18.8M / Jul 30, 2025 | |
RevelAi Health
|
RevelAi Health delivers AI-agent powered care coordination and patient engagement tools to optimize healthcare delivery. By leveraging large language models and machine learning, RevelAi identifies care gaps, automates outreach, and improves outcomes, with a strong emphasis on underserved populations. The platform integrates seamlessly intoclinical systems, aligning with value-based care models and addressing both clinical needs and Social Determinants of Health (SDOH), with a specialization in orthopedic care. | $3.1M / Seed / Jun 18, 2025 | |
Lincode
|
Setting the standard for precision in manufacturing.Lincode is an AI-driven technology company specializing in advanced machine vision and defect detection for automotive, aerospace, and industrial manufacturing. Our patent-pending AI platform leverages pre-trained models to solve complex defect detection challenges, reducing data requirementsand enabling rapid, high-accuracy deployment.With on-premise edge AI deployments, we ensure real-time, low-latency processing, eliminating reliance on the cloud and enhancing production efficiency. Our solutions seamlessly integrate with existing machine vision systems, cutting costs while improving defect detection—especially for subtle flaws like porosity in automotive components.At Lincode, we deliver scalable, cost-effective AI solutions that redefine quality control, helping manufacturers save time, reduce waste, and improve productivity. Trusted by industry leaders in automotive, aerospace, electronics, or packaging our solutions are proven to deliver results where it matters most—on the factory floor. Our system is built to suite the business requirements well without the need of additional rules or programming. With a few simple to use configurations manufacturers can set their quality tolerances per defect or per camera and work with both automation or non automated inspections seamlessly. | $4M / Seed / Dec 10, 2024 | |
Clipp
|
At Clipp, we provide tools for food suppliers to reduce the time they spend managing orders and inventory. Built by industry insiders from food importers, suppliers, and restaurants, our proprietary software offers a complete solution to processes many still manage by paper and pen – including order management, invoicing and inventory tracking.The approach is practical - save money for food distributors and deliver those cost advantages across the supply chain to producers and restaurants. Our mission is to reduce food cost and waste for the world's 8bn+ people. | Pre-Seed / Dec 01, 2024 | |
| See all 391 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does Sand Hill Angels invest in?
Sand Hill Angels invests primarily in Health Care, Software and Biotechnology startups, most often at Seed and Series A stage. Most of the 391 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Sand Hill Angels's check size?
Sand Hill Angels typically joins rounds of $1M–$6.5M at Seed, $1.6M–$24M at Series A and $8.9M–$130M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Sand Hill Angels participates in.
How do I contact Sand Hill Angels?
Public channels for Sand Hill Angels include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Sand Hill Angels?
The team at Sand Hill Angels includes Harper Cheng (Angel Investor), Matt Johnson (Member, Investor) and Ralph Eschenbach (Vice President), among 40 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
